Alterations of the PI3K pathway are frequent in oesophageal cancer: 10% of tumors present with PIK3CA mutations, 23% with PIK3CA amplifications, 10% with PIK3CB amplifications, and 3% with AKT mutations [159]. Here, PIK3CB is linked to carcinoma of esophagus.